Expediting The Expedited: How Rolling CMC Review Process Is Working For COVID-19 Vaccines
US, EU and Canadian authorities recently discussed their approaches to rolling reviews of CMC applications for coronavirus vaccines.
You may also be interested in...
Not all technology platforms provide the expected benefit of filling in CMC review gaps and speeding coronavirus vaccine approvals.
By focusing on short-term stability, US FDA paves way for quicker emergency use authorization without compromising on quality.
A complex transformation is underway as client proposes to acquire CDMO facilities that vaccinated the world against the COVID-19 pandemic for pivot to the obesity epidemic.